Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in Europe

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Tebruegge, Marc ^a,b,c,d   Ritz, Nicole ^d,e   Koetz, Karsten ^f   Noguera Julian, Antoni ^g   Seddon, James A ^h   Welch, Steven B ⁱ   Tsolia, Maria ^j   Kampmann, Beate ^h,k  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF BARCELONA   (Spain)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^j P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^k MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD EXAMINATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EUROPE; FECES ANALYSIS; HEALTH CARE PERSONNEL; HUMAN; JOINT ASPIRATION; LYMPH NODE BIOPSY; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OUTCOME ASSESSMENT; PATIENT CARE; PLEURA FLUID; REAL TIME POLYMERASE CHAIN REACTION; TUBERCULOSIS; TUBERCULOSIS RAPID TEST; WEB BROWSER; HOSPITAL; IMMUNOLOGICAL PROCEDURES; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; STATISTICS AND NUMERICAL DATA; UTILIZATION;

EUROPE; HOSPITALS, PEDIATRIC; IMMUNOLOGIC TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; TUBERCULOSIS;

EID: 84903398859     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099129     Document Type: Article

References (37)

1. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505.
2. Heifets L, Linder T, Sanchez T, Spencer D, Brennan J (2000) Two liquid medium systems, mycobacteria growth indicator tube and MB redox tube, for Mycobacterium tuberculosis isolation from sputum specimens. J Clin Microbiol 38: 1227-1230. (Pubitemid 30140590)
3. Barnard M, Warren R, Gey Van Pittius N, van Helden P, Bosman M, et al. (2012) Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. Am J Respir Crit Care Med 186: 1298-1305.
4. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
5. D'Amato RF, Wallman AA, Hochstein LH, Colaninno PM, Scardamaglia M, et al. (1995) Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test. J Clin Microbiol 33: 1832-1834.
6. Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, et al. (2008) GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 46: 3660-3667.
7. Pfyffer GE, Funke-Kissling P, Rundler E, Weber R (1999) Performance characteristics of the BDProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 37: 137-140. (Pubitemid 29004194)
8. Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, et al. (2005) Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 43: 4880-4884. (Pubitemid 41298302)
9. Vuorinen P, Miettinen A, Vuento R, Hallstrom O (1995) Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol 33: 1856-1859.
10. World Health Organization (2010) News release: WHO endorses new rapid tuberculosis test. Available: http://www.who.int/mediacentre/news/releases/2010/ tb-test-20101208/en/index.html. Accessed 2014 April 14.
11. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, et al. (2013) Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13: 349-361.
12. Lawn SD, Nicol MP (2011) Xpert(R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 6: 1067-1082.
13. World Health Organization (2014) WHO monitoring of Xpert MTB/RIF rollout. Available: http://who.int/tb/laboratory/GeneXpert-rollout-large.jpg. Accessed 2014 April 14.
14. U.S. Food and Drug Administration (2001) Device approvals and clearances: QuantiFERON -TB - P010033. Available: http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsandClearances/ RecentlyApprovedDevices/ucm084025.htm. Accessed 2014 April 14.
15. TebrueggeM, Connell T, Curtis N (2012) Tuberculosis in children. N Engl J Med 367: 1568.
16. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104.
17. Herrera V, Perry S, Parsonnet J, Banaei N (2011) Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 52: 1031-1037.
18. Tebruegge M, Connell T, Ritz N, Bryant PA, Curtis N (2010) Discordance between TSTs and IFN-gamma release assays: the role of NTM and the relevance of mycobacterial sensitins. Eur Respir J 36: 214-215.
19. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R (2007) T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 7: 428-438. (Pubitemid 46779096)
20. Dheda K, van Zyl Smit R, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opinion Pulm Med 15: 188-200.
21. Tebruegge M, Salo E, Ritz N, Kampmann B, on behalf of the Paediatric Tuberculosis Network European Trialsgroup (2013) Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases. Thorax 68: 588.
22. Lawn SD, Kerkhoff AD, Wood R (2012) Location of Xpert(R) MTB/RIF in centralised laboratories in South Africa undermines potential impact. Int J Tuberc Lung Dis; 16: 701.
23. U.S. Food and Drug Administration (2013) Xpert MTB/RIF assay - decision summary. Available: http://www.accessdata.fda.gov/cdrh-docs/reviews/K131706.pdf. Accessed 2014 April 14.
24. Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, et al. (2012) Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 40: 442-447.
25. Hillemann D, Rusch-Gerdes S, Boehme C, Richter E (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 49: 1202-1205.
26. Moure R, Martin R, Alcaide F (2012) Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence. J Clin Microbiol 50: 513-515.
27. Nhu NT, Heemskerk D, Thu do DA, Chau TT, Mai NT, et al. (2014) Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 52: 226-233.
28. Patel VB, Theron G, Lenders L, Matinyena B, Connolly C, et al. (2013) Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med 10: e1001536.
29. Porcel JM, Palma R, Valdes L, Bielsa S, San-Jose E, et al. (2013) Xpert(R) MTB/RIF in pleural fluid for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 17: 1217-1219.
30. Ablanedo-Terrazas Y, Alvarado-de la Barrera C, Hernandez-Juan R, Ruiz-Cruz M, Reyes-Teran G (2013) Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV-infected patients. Laryngoscope (in press). doi: 10.1002/lary.24478
31. Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, et al. (2011) Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. J Clin Microbiol 49: 3967-3970.
32. Nicol MP, Spiers K, Workman L, Isaacs W, Munro J, et al. (2013) Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 57: e18-21.
33. World Health Organization (2013) Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children - policy update. Available: http://www.stoptb.org/wg/gli/assets/documents/WHO%20Pol icy%20Statement%20on%20Xpert%20MTB-RIF%202013%20pre%20publication%2022102013. pdf. Accessed 2014 April 14.
34. World Health Organization (2013) Global tuberculosis report 2013. Available: http://www.who.int/tb/publications/global-report/en/. Accessed 2014 April 14.
35. European Centre for Disease Prevention and Control (2013) Tuberculosis surveillance and monitoring in Europe 2013. Available: http://ecdc.europa.eu/en/ publications/Publications/Tuberculosis-surveillance-monitoring-2013.pdf. Accessed 2014 April 14.
36. Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, et al. (2014) Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 383: 424-435.
37. Nulty DD (2008) The adequacy of response rates to online and paper surveys: what can be done? Assess Eval High Educ 33:301-314.